These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 7570917

  • 1. Elimination of potential mutagenicity in platelet concentrates that are virally inactivated with psoralens and ultraviolet A light.
    Margolis-Nunno H, Robinson R, Ben-Hur E, Chin S, Orme T, Horowitz B.
    Transfusion; 1995 Oct; 35(10):855-62. PubMed ID: 7570917
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Assessment of the hemostatic effectiveness of human platelets treated with aminomethyltrimethyl psoralen and UV A light using a rabbit ear bleeding time technique.
    Wagner SJ, Bardossy L, Moroff G, Dodd RY, Blajchman MA.
    Blood; 1993 Dec 01; 82(11):3489-92. PubMed ID: 8241516
    [Abstract] [Full Text] [Related]

  • 8. Virus sterilization in platelet concentrates with psoralen and ultraviolet A light in the presence of quenchers.
    Margolis-Nunno H, Williams B, Rywkin S, Geacintov N, Horowitz B.
    Transfusion; 1992 Dec 01; 32(6):541-7. PubMed ID: 1502707
    [Abstract] [Full Text] [Related]

  • 9. Inactivation of free and cell-associated human immunodeficiency virus in platelet suspensions by aminomethyltrimethylpsoralen and ultraviolet light.
    Benade LE, Shumaker J, Xu Y, Chen X, Dodd RY.
    Transfusion; 1994 Aug 01; 34(8):680-4. PubMed ID: 8073484
    [Abstract] [Full Text] [Related]

  • 10. Factors influencing virus inactivation and retention of platelet properties following treatment with aminomethyltrimethylpsoralen and ultraviolet A light.
    Moroff G, Wagner S, Benade L, Dodd RY.
    Blood Cells; 1992 Aug 01; 18(1):43-54; discussion 54-6. PubMed ID: 1617192
    [Abstract] [Full Text] [Related]

  • 11. Elimination of cytokine production in stored platelet concentrate aliquots by photochemical treatment with psoralen plus ultraviolet A light.
    Hei DJ, Grass J, Lin L, Corash L, Cimino G.
    Transfusion; 1999 Mar 01; 39(3):239-48. PubMed ID: 10204585
    [Abstract] [Full Text] [Related]

  • 12. The pathogen reduction treatment of platelets with S-59 HCl (Amotosalen) plus ultraviolet A light: genotoxicity profile and hazard assessment.
    Tice RR, Gatehouse D, Kirkland D, Speit G.
    Mutat Res; 2007 Jun 15; 630(1-2):50-68. PubMed ID: 17433761
    [Abstract] [Full Text] [Related]

  • 13. Photochemical inactivation of viruses and bacteria in platelet concentrates by use of a novel psoralen and long-wavelength ultraviolet light.
    Lin L, Cook DN, Wiesehahn GP, Alfonso R, Behrman B, Cimino GD, Corten L, Damonte PB, Dikeman R, Dupuis K, Fang YM, Hanson CV, Hearst JE, Lin CY, Londe HF, Metchette K, Nerio AT, Pu JT, Reames AA, Rheinschmidt M, Tessman J, Isaacs ST, Wollowitz S, Corash L.
    Transfusion; 1997 Apr 15; 37(4):423-35. PubMed ID: 9111281
    [Abstract] [Full Text] [Related]

  • 14. Inactivation of Trypanosoma cruzi trypomastigote forms in blood components with a Psoralen and Ultraviolet A light.
    Gottlieb P, Margolis-Nunno H, Robinson R, Shen LG, Chimezie E, Horowitz B, Ben-Hur E.
    Photochem Photobiol; 1996 May 15; 63(5):562-5. PubMed ID: 8628745
    [Abstract] [Full Text] [Related]

  • 15. Treatment of T. cruzi infected human platelet concentrates with aminomethyltrimethyl psoralen (AMT) and ultraviolet A (UV-A) light: preliminary results.
    Moraes-Souza H, Bordin JO, Bardossy L, Blajchman MA.
    Rev Soc Bras Med Trop; 1996 May 15; 29(1):47-9. PubMed ID: 8851215
    [Abstract] [Full Text] [Related]

  • 16. Psoralen photochemical inactivation of Orientia tsutsugamushi in platelet concentrates.
    Belanger KJ, Kelly DJ, Mettille FC, Hanson CV, Lippert LE.
    Transfusion; 2000 Dec 15; 40(12):1503-7. PubMed ID: 11134571
    [Abstract] [Full Text] [Related]

  • 17. Photochemical treatment of platelet concentrates with amotosalen hydrochloride and ultraviolet A light inactivates free and latent cytomegalovirus in a murine transfusion model.
    Jordan CT, Saakadze N, Newman JL, Lezhava LJ, Maiers TT, Hillyer WM, Roback JD, Hillyer CD.
    Transfusion; 2004 Aug 15; 44(8):1159-65. PubMed ID: 15265119
    [Abstract] [Full Text] [Related]

  • 18. Inactivation of viruses in platelet suspensions that retain their in vitro characteristics: comparison of psoralen-ultraviolet A and merocyanine 540-visible light methods.
    Dodd RY, Moroff G, Wagner S, Dabay MH, Dorfman E, George V, Ribeiro A, Shumaker J, Benade LE.
    Transfusion; 1991 Aug 15; 31(6):483-90. PubMed ID: 1853439
    [Abstract] [Full Text] [Related]

  • 19. Photochemical inactivation of bacteria and HIV in buffy-coat-derived platelet concentrates under conditions that preserve in vitro platelet function.
    Knutson F, Alfonso R, Dupuis K, Mayaudon V, Lin L, Corash L, Högman CF.
    Vox Sang; 2000 Aug 15; 78(4):209-16. PubMed ID: 10895093
    [Abstract] [Full Text] [Related]

  • 20. Induction of SCE by DNA cross-links in human fibroblasts exposed to 8-MOP and UVA irradiation.
    Bredberg A, Lambert B.
    Mutat Res; 1983 Aug 15; 118(3):191-204. PubMed ID: 6877268
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.